ClinicalTrials.gg
RecruitingNCT05823688PulmopneumoUpdated May 10, 2024

Electrical Impedance Tomography (EIT) Monitoring of Regional Ventilation During Pediatric Laparoscopy

An observational study in Pediatric Anesthesia, Laparoscopy and Ventilation, sponsored by Vittore Buzzi Children's Hospital. Recruiting at 1 site in Italy. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2024-05-10.

Sponsored by Vittore Buzzi Children's Hospital · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 4 months ago, but the record still lists the study as recruiting.
  • Started May 2023; still recruiting 3 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
10 Years to 18 Years
Sex
All
01

Study summary

The goal of this prospective, observational study is to describe EIT measurements at different time points during the perioperative period in healthy children undergoing laparoscopic surgery. The objective is to evaluate the impact of general anesthesia and laparoscopy on regional pulmonary ventilation visualized at EIT during the perioperative period.

Read the detailed description

Electrical impedance tomography (EIT) is a non-invasive, radiation-free functional imaging technique based on image reconstruction of pulmonary regional ventilation by estimating the changes in resistivity (impedance) that occur in the lungs during respiration. Validation data confirms that EIT is highly reproducible and that impedance changes accurately reflect changes in regional ventilation. This allows for the derivation of EIT-derived measurements that can be used to assess bedside regional lung function.

In clinical practice there is increasing emphasis on understanding the impact of anesthesia and mechanical ventilation on regional pulmonary ventilation in order to improve clinical outcomes, including in children.

Several studies have demonstrated that the benefits of using EIT to set ventilatory parameters, improving gas exchange and respiratory mechanics are also applicable outside the intensive care unit. For example, monitoring of changes in regional ventilation in the operating room in adults has been studied to guide intraoperative ventilation setting and adopt it as a strategy to prevent anesthesia-induced atelectasis.

The impact on regional pulmonary ventilation distribution may be significant in situations such as laparoscopic surgery, where capnoperitoneum and Trendelenburg position pose an additional risk of deterioration of respiratory function and may contribute to the development of early postoperative pulmonary complications.In the adult population, studies demonstrate that pneumoperitoneum during laparoscopy can influence the distribution of ventilation together with anesthesia and mechanical ventilation in different ways. In contrast, regional ventilation changes during laparoscopy are still lacking for the pediatric population.

The aim of the present study is to investigate how general anesthesia and capnoperitoneum during laparoscopic procedures can affect the distribution of regional ventilation displayed by EIT in healthy pediatric patients and how these changes correlate with ventilatory parameters and clinical outcomes.

02

Conditions studied

  • Pediatric Anesthesia
  • Laparoscopy
  • Ventilation
03

In context

Lead sponsor

Vittore Buzzi Children's Hospital is the lead sponsor of 10 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Pediatric patients age 10-18 undergoing laparoscopic procedures

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ASA Status I and II
  • elective or urgent laparoscopic procedures (e.g., appendectomy, cholecystectomy, varicocelectomy)

Exclusion criteria

Exclusion Criteria:

  • Lack of parental consent
  • ASA status III-IV
  • Presence of peritonitis or other abdominal inflammatory process that could potentially interfere with spontaneous breathing ventilation
  • Need for immediate resuscitation maneuvers
  • Severe respiratory illness in the previous 4-6 weeks
  • Pre-existing chronic pulmonary conditions
  • Concomitant acute pulmonary conditions (e.g. pneumonia, pleural effusion)
  • Cardiac arrest
  • Skeletal deformities (e.g. rib cage malformations or scoliosis), neuromuscular diseases or cardiac conditions affecting respiratory mechanics
  • > 30
  • Presence of implantable devices not compatible with EIT (such as pacemakers and implantable defibrillators)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (estimated)
Patient registry
No

Interventions

  • DeviceElectrical Impedance Tomography

    Measure of regional ventilation by Electrical Impedance Tomography (EIT) before and during pneumoperitoneum

06

What researchers measure

Primary outcomes

  1. Regional Ventilation distribution

    Difference in regional ventilation distribution before and after institution of pneumoperitoneum

    Time frame: Intraoperative

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2023 (actual). Primary completion is estimated for Jun 2024, 13 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 8, 2023
First posted
Apr 21, 2023
StartActual
May 1, 2023
Primary completionEst.
Jun 30, 2024
CompletionEst.
Dec 31, 2024
Last update
May 10, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05823688
Lead sponsor
Vittore Buzzi Children's Hospital
Responsible party
Anna Camporesi (Principal Investigator, Vittore Buzzi Children's Hospital) — Principal investigator
First posted
Apr 21, 2023
Start date
May 1, 2023
Primary completion
Jun 30, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
May 10, 2024

Study contacts

Anna Camporesi, M.D.
Contact
anna.camporesi@asst-fbf-sacco.it
+393355793744

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion